Revvity Blog
Powering innovation from discovery to cure.
Latest
How conditional bispecific antibodies are advancing precision immunotherapy.
Cancer
August 14, 2025 - 2 min read
Small Molecule Drug Discovery
Antidepressant shows potential for treating COVID-19.
June 7, 2024 -
2 min read
Small Molecule Drug Discovery
Second messenger assays bring clarity to cardiovascular research.
June 7, 2024 -
3 min read
Small Molecule Drug Discovery
Retinoic acid focus yields insight into neuroinflammation therapy.
June 7, 2024 -
3 min read
Small Molecule Drug Discovery
Opening the door to additional CAR-T cell therapies in cancer.
June 7, 2024 -
3 min read
Small Molecule Drug Discovery
New technologies in multiple sclerosis drug discovery.
June 7, 2024 -
5 min read
Small Molecule Drug Discovery
Key facts about neuroinflammation involvement in Alzheimer’s disease.
June 7, 2024 -
5 min read
Small Molecule Drug Discovery
Kinase investigations open new doors in Oncology and Neuroscience.
June 6, 2024 -
2 min read
Small Molecule Drug Discovery
In the treatment of human cancer, KRAS remains an untouchable target of choice.
June 6, 2024 -
5 min read
Small Molecule Drug Discovery
New hope for Huntington’s disease drug discovery.
June 6, 2024 -
4 min read
Small Molecule Drug Discovery
Impact of FGFRs dysregulation in oncogenic mechanisms.
June 6, 2024 -
4 min read